181 related articles for article (PubMed ID: 16672771)
21. Wound healing angiogenesis: indirect stimulation by basic fibroblast growth factor.
Knighton DR; Phillips GD; Fiegel VD
J Trauma; 1990 Dec; 30(12 Suppl):S134-44. PubMed ID: 1701493
[TBL] [Abstract][Full Text] [Related]
22. Potential anti-angiogenic role of Slit2 in corneal neovascularization.
Han X; Zhang MC
Exp Eye Res; 2010 Jun; 90(6):742-9. PubMed ID: 20298689
[TBL] [Abstract][Full Text] [Related]
23. A siRNA targeting vascular endothelial growth factor-A inhibiting experimental corneal neovascularization.
Zuo L; Fan Y; Wang F; Gu Q; Xu X
Curr Eye Res; 2010 May; 35(5):375-84. PubMed ID: 20450250
[TBL] [Abstract][Full Text] [Related]
24. Effects of trehalose on VEGF-stimulated angiogenesis and myofibroblast proliferation: implications for glaucoma filtration surgery.
Takeuchi K; Nakazawa M; Ebina Y
Invest Ophthalmol Vis Sci; 2011 Sep; 52(9):6987-93. PubMed ID: 21778273
[TBL] [Abstract][Full Text] [Related]
25. Chemical injury-induced corneal opacity and neovascularization reduced by rapamycin via TGF-β1/ERK pathways regulation.
Shin YJ; Hyon JY; Choi WS; Yi K; Chung ES; Chung TY; Wee WR
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4452-8. PubMed ID: 23716625
[TBL] [Abstract][Full Text] [Related]
26. Blockade of EphA receptor tyrosine kinase activation inhibits vascular endothelial cell growth factor-induced angiogenesis.
Cheng N; Brantley DM; Liu H; Lin Q; Enriquez M; Gale N; Yancopoulos G; Cerretti DP; Daniel TO; Chen J
Mol Cancer Res; 2002 Nov; 1(1):2-11. PubMed ID: 12496364
[TBL] [Abstract][Full Text] [Related]
27. Isoliquiritigenin from licorice root suppressed neovascularisation in experimental ocular angiogenesis models.
Jhanji V; Liu H; Law K; Lee VY; Huang SF; Pang CP; Yam GH
Br J Ophthalmol; 2011 Sep; 95(9):1309-15. PubMed ID: 21719569
[TBL] [Abstract][Full Text] [Related]
28. HGF/NK4, a four-kringle antagonist of hepatocyte growth factor, is an angiogenesis inhibitor that suppresses tumor growth and metastasis in mice.
Kuba K; Matsumoto K; Date K; Shimura H; Tanaka M; Nakamura T
Cancer Res; 2000 Dec; 60(23):6737-43. PubMed ID: 11118060
[TBL] [Abstract][Full Text] [Related]
29. A Novel Peptide Derived From Tissue-Type Plasminogen Activator Potently Inhibits Angiogenesis and Corneal Neovascularization.
Kim HK; Choi JS; Lee SW; Joo CK; Joe YA
J Cell Biochem; 2017 May; 118(5):1132-1143. PubMed ID: 27618679
[TBL] [Abstract][Full Text] [Related]
30. A potential therapeutic strategy for inhibition of corneal neovascularization with new anti-VEGF agents.
Hosseini H; Nejabat M
Med Hypotheses; 2007; 68(4):799-801. PubMed ID: 17107753
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of inflammatory corneal angiogenesis by TNP-470.
Joussen AM; Beecken WD; Moromizato Y; Schwartz A; Kirchhof B; Poulaki V
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2510-6. PubMed ID: 11581191
[TBL] [Abstract][Full Text] [Related]
32. Peptides encoded by exon 6 of VEGF inhibit endothelial cell biological responses and angiogenesis induced by VEGF.
Jia H; Jezequel S; Löhr M; Shaikh S; Davis D; Soker S; Selwood D; Zachary I
Biochem Biophys Res Commun; 2001 Apr; 283(1):164-73. PubMed ID: 11322784
[TBL] [Abstract][Full Text] [Related]
33. Suppression of corneal neovascularization by culture supernatant of human amniotic cells.
Kobayashi N; Kabuyama Y; Sasaki S; Kato K; Homma Y
Cornea; 2002 Jan; 21(1):62-7. PubMed ID: 11805510
[TBL] [Abstract][Full Text] [Related]
34. Localization of angiotensin converting enzyme in rabbit cornea and its role in controlling corneal angiogenesis in vivo.
Sharma A; Bettis DI; Cowden JW; Mohan RR
Mol Vis; 2010 Apr; 16():720-8. PubMed ID: 20431722
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of pathological corneal neovascularization by a small peptide derived from human apolipoprotein (a) Kringle V.
Wang Z; Zhao H; Ma JX; Xu X
Cornea; 2014 Apr; 33(4):405-13. PubMed ID: 24452210
[TBL] [Abstract][Full Text] [Related]
36. Corneal Neovascularization: A Combined Approach of Bevacizumab and Suramin Showed Increased Antiangiogenic Effect Through Downregulation of BFGF and P
Lopez ES; Ortiz GA; Potilinski C; Croxatto JO; Gallo JE
Curr Eye Res; 2018 Apr; 43(4):466-473. PubMed ID: 29265937
[TBL] [Abstract][Full Text] [Related]
37. Correlation of VEGF expression by leukocytes with the growth and regression of blood vessels in the rat cornea.
Edelman JL; Castro MR; Wen Y
Invest Ophthalmol Vis Sci; 1999 May; 40(6):1112-23. PubMed ID: 10235544
[TBL] [Abstract][Full Text] [Related]
38. Luteolin inhibits vascular endothelial growth factor-induced angiogenesis; inhibition of endothelial cell survival and proliferation by targeting phosphatidylinositol 3'-kinase activity.
Bagli E; Stefaniotou M; Morbidelli L; Ziche M; Psillas K; Murphy C; Fotsis T
Cancer Res; 2004 Nov; 64(21):7936-46. PubMed ID: 15520200
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of ocular neovascularization by a novel peptide derived from human placenta growth factor-1.
Zheng Y; Gu Q; Xu X
Acta Ophthalmol; 2012 Nov; 90(7):e512-23. PubMed ID: 22994140
[TBL] [Abstract][Full Text] [Related]
40. Sustained intraocular rapamycin delivery effectively prevents high-risk corneal allograft rejection and neovascularization in rabbits.
Shi W; Gao H; Xie L; Wang S
Invest Ophthalmol Vis Sci; 2006 Aug; 47(8):3339-44. PubMed ID: 16877400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
